Israel Englander Bluebird Bio, Inc. Put Options Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BLUE
# of Institutions
67Shares Held
39.7MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$112 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$33.8 Million0.02% of portfolio
-
Avidity Partners Management LP Dallas, TX1.63MShares$11.8 Million0.05% of portfolio
-
Northern Trust Corp Chicago, IL1.54MShares$11.1 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.41MShares$10.2 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $559M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...